HBx transgenic mice gradually developed steatosis, dysplastic nodules and visible HCC by 12 months, accompanied by hepatic expression of SHh, IHh, PTCH1 and GLI2. This evidence concerns the gene PTCH1 and hepatocellular carcinoma.